| Description: | Sequence 2 from patent US 7247431. Human source gene leading sequence, gene vector, gene targeting site and gene expression stragegy. A Cell Line Expressing Mutated Human Tissue-Type Plasminogen Activator, Its Construction Strategy and Method of Expressed Protein Preparation. Sequence 1 from patent US 7632677. | |
| Length: | 11162 bp | |
| Found in databases: | nrnl1 | |
| Found in the following 5 patents: | US7247431 (lens, espacenet) US2004137437 (lens, espacenet) JP2004508046 (lens, espacenet) JP2004508066 (lens, espacenet) US7632677 (lens, espacenet) | |
View these methods in JRC GMO-Matrix
| Event-specific method | |
| Element-specific method | |
| Construct-specific method | |
| Taxon-specific method |
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| NRN_EA270624 | nrnl1 | Sequence 2 from patent US 7247431. ... | 11162 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
| NRN_EA270624 | nrnl1 | Sequence 2 from patent US 7247431. ... | 11162 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.